TL;DR: BRN 0946137 (CAS 38911-89-6) is a chemical compound with molecular formula C21H21N5O2S and molecular weight 407.1416 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
ethyl 2-[[5-[2-(1H-benzimidazol-2-yl)ethyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetate
Also Known As: BAS 02993315, 5-26-19-00024 (Beilstein Handbook Reference), Acetic acid, ((5-(2-(1H-benzimidazol-2-yl)ethyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)-, ethyl ester, BRD-K25269603-001-01-6, [[5-[2-(1H-Benzimidazol-2-yl)ethyl]-4-phenyl-4H-1,2,4-triazol-3-yl]thio]acetic acid ethyl ester
| Molecular Formula | C21H21N5O2S |
| Molecular Weight | 407.1416 g/mol |
| XLogP | 4.1 |
| Topological Polar Surface Area (TPSA) | 111.0 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Exact Mass | 407.1416 Da |
| Heavy Atoms | 29 |
| Complexity | 533.0 |
| SMILES | CCOC(=O)CSC1=NN=C(N1C2=CC=CC=C2)CCC3=NC4=CC=CC=C4N3 |
| InChIKey | IJADJCLZZNQISU-UHFFFAOYSA-N |
The XLogP value of 4.1 indicates that BRN 0946137 is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 111.0 Ų falls within the moderate polarity range, balancing permeability and solubility for BRN 0946137. Following Lipinski's Rule of Five, BRN 0946137 has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of BRN 0946137 is 38911-89-6.
The molecular formula of BRN 0946137 is C21H21N5O2S.
The molecular weight of BRN 0946137 is 407.1416 g/mol.
You can request a quote for BRN 0946137 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for BRN 0946137 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 38911-89-6. Our professional technical team will respond with pricing and lead time.